sr141716 has been researched along with Pyrexia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adolfs, TJ; Coolen, HK; de Jong, NM; den Hartog, AP; Dijksman, JA; Herremans, AH; Hoogendoorn, J; Keizer, HG; Kruse, CG; Lange, JH; McCreary, AC; Ronken, E; Stork, B; Tipker, K; van Stuivenberg, HH; Veerman, W; Verveer, PC; Wals, HC | 1 |
| Taffe, MA | 1 |
| Arnaud, C; Demenge, P; Godin-Ribuot, D; Joyeux, M; Lamontagne, D; Ribuot, C | 1 |
| Hunt, GE; Li, KM; Mallet, PE; McGregor, IS; Morley, KC | 1 |
| Abe, K; Egashira, N; Fujiwara, M; Hasebe, N; Hayakawa, K; Ikeda, T; Inui, K; Iwasaki, K; Mishima, K; Takamatsu, F; Yasuda, H | 1 |
| Adler, MW; Benamar, K; Eisenstein, TK; Geller, EB; Meissler, JJ; Tallarida, RJ; Yondorf, M | 1 |
6 other study(ies) available for sr141716 and Pyrexia
| Article | Year |
|---|---|
Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonists.
Topics: Administration, Oral; Animals; Arachidonic Acid; Binding, Competitive; Biological Availability; CHO Cells; Cricetinae; Crystallography, X-Ray; Fever; Humans; Hypotension; Male; Mice; Models, Molecular; Molecular Conformation; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB1; Stereoisomerism; Structure-Activity Relationship; Sulfonamides | 2004 |
Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Body Temperature; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Fever; Hallucinogens; Macaca mulatta; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rimonabant; Telemetry; Time Factors | 2012 |
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts.
Topics: Analysis of Variance; Animals; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Endocannabinoids; Fever; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors | 2002 |
Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats.
Topics: Animals; Cannabinoids; Cyclohexanols; Fever; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Serotonin | 2004 |
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.
Topics: Analysis of Variance; Animals; Body Temperature; Brain Infarction; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fever; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Tetrazolium Salts; Time Factors | 2004 |
A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.
Topics: Animals; Benzoxazines; Binding, Competitive; Body Temperature; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dronabinol; Fever; Interleukin-6; Lipopolysaccharides; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant | 2007 |